Contemporary Challenges in the EU Pharmaceutical Industry: A Systematic Literature Review

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F70883521%3A28120%2F21%3A63529858" target="_blank" >RIV/70883521:28120/21:63529858 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Contemporary Challenges in the EU Pharmaceutical Industry: A Systematic Literature Review

Popis výsledku v původním jazyce

The COVID-19 global pandemic has broken healthcare systems globally and locally in this on-going uncertain time. In that instance, the European Union (EU) was not an exception. The main aim of this study is to highlight the contemporary challenges faced by the pharmaceutical industry in the European Union region (EU). Importantly, this topic is emerging but under-researched in the existing literature. For this reason, this study attempts to bridge the research gap by examining the issues. Methodologically, this study employed a systematic literature review method to generate new knowledge. Our study conducted data analysis with Microsoft Excel software. This study analysed 27 published studies from Web of Science, Scopus, and indexed journals from the top reputed Chartered Association of Business Schools (CABS). Our study highlighted the complexity of EU pharmaceutical industry through the systematic literature review method. The systematic review revealed that the vulnerability of EU pharmaceutical industry, such as default patent system, ineffective research and development (R&amp;D), debate on the role of alliances, low level of expertise in EU health care system and pharmaceutical supply chain management.

Název v anglickém jazyce

Contemporary Challenges in the EU Pharmaceutical Industry: A Systematic Literature Review

Popis výsledku anglicky

The COVID-19 global pandemic has broken healthcare systems globally and locally in this on-going uncertain time. In that instance, the European Union (EU) was not an exception. The main aim of this study is to highlight the contemporary challenges faced by the pharmaceutical industry in the European Union region (EU). Importantly, this topic is emerging but under-researched in the existing literature. For this reason, this study attempts to bridge the research gap by examining the issues. Methodologically, this study employed a systematic literature review method to generate new knowledge. Our study conducted data analysis with Microsoft Excel software. This study analysed 27 published studies from Web of Science, Scopus, and indexed journals from the top reputed Chartered Association of Business Schools (CABS). Our study highlighted the complexity of EU pharmaceutical industry through the systematic literature review method. The systematic review revealed that the vulnerability of EU pharmaceutical industry, such as default patent system, ineffective research and development (R&amp;D), debate on the role of alliances, low level of expertise in EU health care system and pharmaceutical supply chain management.

Druh

D - Stať ve sborníku

CEP obor

—

OECD FORD obor

50204 - Business and management

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

Managing Knowledge in Uncertain Times PROCEEDINGS

ISBN

978-88-96687-14-7

ISSN

2280-787X

e-ISSN

—

Počet stran výsledku

14

Strana od-do

717-730

Název nakladatele

International Forum on Knowledge Asset Dynamics

Místo vydání

Řím

Místo konání akce

Řím

Datum konání akce

1. 9. 2021

Typ akce podle státní příslušnosti

EUR - Evropská akce

Kód UT WoS článku

—